Safety and efficacy of an implantable device for management of gastroesophageal reflux in lung transplant recipients.

ABSTRACT:

Background

Magnetic sphincter augmentation (MSA) is a promising minimally invasive surgical technique for management of gastroesophageal reflux disease (GERD); however, device implantation after transplantation has not been studied and may be concerning in these immunosuppressed patients. We explored the safety of the LINX Reflux Management System (MSA device) for management of GERD following lung transplantation (LTx).

Methods

Lung transplant recipients who underwent LINX implantation at our institution between 2017 and 2019 were followed prospectively in the Reflux Following Lung Transplantation and Associated Treatment Registry. Ambulatory pH testing and acid-suppressing medication use were compared before and after LINX implantation. One-year outcomes and change in pulmo

SUBMITTER: Halpern SE 

PROVIDER: S-EPMC8107527 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature